<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14</volume><submitter>Gatta E</submitter><pubmed_abstract>&lt;h4>Purpose&lt;/h4>To characterize patients with APS type 4 among those affected by APS diagnosed and monitored at our local Reference Center for Autoimmune Polyglandular Syndromes.&lt;h4>Methods&lt;/h4>Monocentric observational retrospective study enrolling patients affected by APS diagnosed and monitored in a Reference Center. Clinical records were retrieved and analyzed.&lt;h4>Results&lt;/h4>111 subjects (51 males) were affected by APS type 4, mean age at the onset was 23.1 ± 15.1 years. In 15 patients the diagnosis of APS was performed during the first clinical evaluation, in the other 96 after a latency of 11 years (range 1-46). The most frequent diseases were type I diabetes mellitus and celiac disease, equally distributed among sexes.&lt;h4>Conclusions&lt;/h4>The prevalence of APS type 4 is 9:100,000 people. Type I diabetes mellitus was the leading indicator of APS type 4 in 78% subjects and in 9% permitted the diagnosis occurring as second manifestation of the syndrome. Our data, showing that 50% of patients developed APS type 4 within the first ten years, don't suggest any particular follow-up time and, more importantly, don't specify any particular disease. It is important to emphasize that 5% of women developed premature ovarian failure.</pubmed_abstract><journal>Frontiers in endocrinology</journal><pagination>1236878</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10627240</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Autoimmune polyglandular syndrome type 4: experience from a single reference center.</pubmed_title><pmcid>PMC10627240</pmcid><pubmed_authors>Agosti B</pubmed_authors><pubmed_authors>Mazzola AM</pubmed_authors><pubmed_authors>Maltese V</pubmed_authors><pubmed_authors>Buoso C</pubmed_authors><pubmed_authors>Lupo R</pubmed_authors><pubmed_authors>Pezzaioli LC</pubmed_authors><pubmed_authors>Cimino E</pubmed_authors><pubmed_authors>Fredi M</pubmed_authors><pubmed_authors>Zammarchi I</pubmed_authors><pubmed_authors>Pirola I</pubmed_authors><pubmed_authors>Di Lodovico E</pubmed_authors><pubmed_authors>Gozzoli G</pubmed_authors><pubmed_authors>Licini M</pubmed_authors><pubmed_authors>Cavadini M</pubmed_authors><pubmed_authors>Bambini F</pubmed_authors><pubmed_authors>Cappelli C</pubmed_authors><pubmed_authors>Bezzi F</pubmed_authors><pubmed_authors>Bremi W</pubmed_authors><pubmed_authors>Girelli A</pubmed_authors><pubmed_authors>Anelli V</pubmed_authors><pubmed_authors>Franceschini F</pubmed_authors><pubmed_authors>Gatta E</pubmed_authors><pubmed_authors>Delbarba A</pubmed_authors><pubmed_authors>Marini F</pubmed_authors><pubmed_authors>Ricci C</pubmed_authors><pubmed_authors>Piovani E</pubmed_authors><pubmed_authors>Facondo P</pubmed_authors><pubmed_authors>Saullo M</pubmed_authors><pubmed_authors>Alfieri D</pubmed_authors><pubmed_authors>Gandossi E</pubmed_authors><pubmed_authors>Pini L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Autoimmune polyglandular syndrome type 4: experience from a single reference center.</name><description>&lt;h4>Purpose&lt;/h4>To characterize patients with APS type 4 among those affected by APS diagnosed and monitored at our local Reference Center for Autoimmune Polyglandular Syndromes.&lt;h4>Methods&lt;/h4>Monocentric observational retrospective study enrolling patients affected by APS diagnosed and monitored in a Reference Center. Clinical records were retrieved and analyzed.&lt;h4>Results&lt;/h4>111 subjects (51 males) were affected by APS type 4, mean age at the onset was 23.1 ± 15.1 years. In 15 patients the diagnosis of APS was performed during the first clinical evaluation, in the other 96 after a latency of 11 years (range 1-46). The most frequent diseases were type I diabetes mellitus and celiac disease, equally distributed among sexes.&lt;h4>Conclusions&lt;/h4>The prevalence of APS type 4 is 9:100,000 people. Type I diabetes mellitus was the leading indicator of APS type 4 in 78% subjects and in 9% permitted the diagnosis occurring as second manifestation of the syndrome. Our data, showing that 50% of patients developed APS type 4 within the first ten years, don't suggest any particular follow-up time and, more importantly, don't specify any particular disease. It is important to emphasize that 5% of women developed premature ovarian failure.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2024-11-07T02:30:36.872Z</modification><creation>2024-11-07T02:30:36.872Z</creation></dates><accession>S-EPMC10627240</accession><cross_references><pubmed>37937054</pubmed><doi>10.3389/fendo.2023.1236878</doi></cross_references></HashMap>